UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Discover effective wealth accumulation strategies for retirement that will help you secure a comfortable financial future. Start planning your retirement now.
13,750 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Investors are parsing sector headlines as analysts cut targets for airlines and other cyclical stocks. This guide bre...
A fresh look at how to read Lifetime Brands' Q4 2025 earnings transcript. This guide explains key metrics, growth dri...
Geopolitical tensions are sparking volatility in the helium market. This report explains how a disruption in helium s...
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...
Oil moved toward $110 a barrel after Iran signaled a broader escalation. The move adds risk to already tense energy m...
The World Gold Council unveiled a blockchain-backed trust layer to link physical gold vaults with digital rails, sign...
Lenders posted healthier profits per loan in Q3 2025, but declined loans still drain resources. A new declined loan a...
Three ETFs have stood out in 2026 by delivering positive returns while the S&P 500 retreats. RSP, NLR, and VXUS are t...
One of Wall Street’s hottest hedge funds is riding a two-trade surge, concentrated in Nvidia and Meta Platforms, as i...
Ford is retreating from broad EV production while Toyota accelerates its electrification push, setting up a decisive ...
Rising prices are forcing many Americans to trim travel budgets. This guide helps you plan smarter trips, maximize va...